Vericel Corp Ord (VCEL)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.91B
Last updated: Nov 17, 2026 at 11:05 AM ET
Vericel Corp Ord (VCEL) Stock Forecast
Analysts expect Vericel Corp Ord (VCEL) to earn $0.75 per share in the fiscal year ending Dec 31, 2026, on revenue of $345.27M. Of 8 analysts, 7 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 2.13, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 88% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 7 | 87.5% |
| Hold | 1 | 12.5% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 8
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 25.3% and revenue estimates rise 15.4%.
- Fiscal year ending Dec 31, 2026
- $0.75
- EPS consensus, revenue $345.27M
- Fiscal year ending Dec 31, 2027
- $0.94
- EPS consensus, revenue $398.34M
- Next report
- Feb 24, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.75 | $0.67 to $0.80 | 5 | $345.27M | $344.43M to $345.80M | 8 |
| Dec 31, 2027 | $0.94 | $0.82 to $1.14 | 5 | $398.34M | $389.61M to $412.37M | 8 |
Quarterly Estimates
The EPS consensus falls from $0.58 for the quarter ending Dec 31, 2026 to -$0.03 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.58 | $0.46 to $0.65 | 10 | $116.31M | $110.91M to $120.33M | 10 |
| Mar 31, 2027 | -$0.03 | -$0.09 to $0.02 | 5 | $80.31M | $74.30M to $84.10M | 7 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 3 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 44.2% from $0.52.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.75 | $0.52 | $0.52 | $0.52 | $0.52 | +44.6% |
| Fiscal year ending Dec 31, 2027 | $0.94 | $0.85 | $0.85 | $0.85 | $0.85 | +11.3% |
| Quarter ending Mar 31, 2027 | -$0.03 | -$0.06 | -$0.06 | -$0.06 | -$0.06 | N/A |
Frequently Asked Questions About VCEL
What is the VCEL stock forecast?
Consensus analyst estimates put Vericel Corp Ord's EPS at $0.75 for the fiscal year ending Dec 31, 2026, on revenue of $345.27M. The consensus rating from 8 analysts is Buy.
How do analysts rate VCEL stock?
Of 8 analysts covering Vericel Corp Ord, 0 rate it Strong Buy, 7 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from VCEL next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.75, with estimates from $0.67 to $0.80 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.94, with estimates from $0.82 to $1.14 from 5 analysts.
What revenue do analysts expect from Vericel Corp Ord next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $345.27M, with estimates from $344.43M to $345.80M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $398.34M, with estimates from $389.61M to $412.37M.
How many analysts cover VCEL?
8 analysts rate Vericel Corp Ord stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
VCEL pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors